Loading insider details...
Latest Form 4 (May 29, 2026): Grant/Award of 120,000 TNYA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 29, 2026 | Tenaya Therapeutics, Inc. (TNYA) | Grant/Award | 120,000 | n/a |
| May 5, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Tender of Shares | 146,614 | $7.77M |
| Mar 17, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Exercise/Conversion | 14,583 | $67.7K |
| Feb 19, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Exercise/Conversion | 14,583 | $67.7K |
| Jan 16, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Grant/Award | 150,000 | n/a |
| Jan 7, 2026 | Terns Pharmaceuticals, Inc. (TERN) | Exercise/Conversion | 21,551 | $100.0K |
| Jun 25, 2025 | Terns Pharmaceuticals, Inc. (TERN) | Purchase | 23,314 | $90.2K |
| May 30, 2025 | Tenaya Therapeutics, Inc. (TNYA) | Grant/Award | 107,400 | n/a |
| Feb 4, 2025 | Terns Pharmaceuticals, Inc. (TERN) | Purchase | 510 | $2.6K |
| Dec 9, 2024 | Terns Pharmaceuticals, Inc. (TERN) | Purchase | 15,450 | $110.5K |